David Bentley, 2004-05-14
Scope and Contents
David Bentley, geneticist and a founding member of the management team of the Wellcome Trust Sanger Institute, is interviewed by Mila Pollock on May 14, 2004, at Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. David Bentley's interview discusses the following topics: Scene 1. Becoming a scientist -- Scene 2. Alternative career paths -- Scene 3. Involvement in genomics -- Scene 4. Mapping human chromosomes -- Scene 5. Mechanics of the HGP: 1986 meeting at the Medical Research Council -- Scene 6. John Sulston -- Scene 7. 'Bermuda Principles' meetings -- Scene 8. Surprises in the HGP: scaling up -- Scene 9. International collaboration -- Scene 10. International collaboration: progress across borders -- Scene 11. Dangers of genetic information: ethical considerations -- Scene 12. Benefits of the human genetic sequence and its interpretation -- Scene 13. Dangers of genomic research: the possibility of misusing information -- Scene 14. Gene patenting -- Scene 15. Challenges of the HGP: communication across scientific disciplines -- Scene 16. Involvement in genomics: current research -- Scene 17. Career satisfaction -- Scene 18. Future of genomics: genomics, five years from now -- Scene 19. Competition in science -- Scene 20. Advice to young scientists -- Scene 21. Jim Watson, first encounter -- Scene 22. Francis Collins -- Scene 23. Cold Spring Harbor Laboratory meetings -- Scene 24. 2004 meeting: Biology of Genomes.
- Bentley, David (David R.) (Interviewee, Person)
Conditions Governing Access
Portions of this collection have been digitized and are available online: https://library.cshl.edu/oralhistory/. Some tapes have been digitized thanks to support from CLIR Recordings at Risk Grant awarded in 2021, these tapes are not yet available online but are available for research in person at CSHL Archives. Please contact CSHL Archives firstname.lastname@example.org with any questions regarding availability.
Biographical / Historical
David Bentley, molecular biologist and geneticist, is currently Vice President and Chief Scientist of DNA Sequencing at Illumina, Inc., a commercial developer of genetic analysis tools and systems.
Educated at the University of Cambridge (M.A. in biochemistry) and the University of Oxford (Ph. D.), Dr. Bentley was a postdoctoral fellow, lecturer, and senior lecturer at Guy's and St. Thomas's Hospital in London from 1991 to 1993 where he studied mutations that cause genetic diseases, and a Senior Lecturer in the Division of Medical & Molecular Genetics at the University of London.
In 1993 he was brought to Sanger Centre (now known as Wellcome Trust Sanger Institute) as a founding member and head of human genetics by his mentor, John Sulston. Dr. Bentley led Sanger in their major contributions to the Human Genome Project, The Single Nucleotide Polymorphisms (SNP) Consortium, and the International Haplotype Mapping (HapMap) Project. Dr. Bentley left Wellcome in 1985 to join commercial sequencer, Solexa, Inc., as Chief Scientist where he was responsible for the Company’s DNA sequencing applications development and projects. Solexa was acquired by Illumina in 2007.
1 Cassettes (Camcorder footage) : MiniDV - CSHL1017 (Also contains Yang Huanming) ; 35 min
Language of Materials
From the Collection: English
Interview recorded on Mini DV, then transferred to DVD.